Table 2 Endosialin expression in tumour-associated stroma in relation to clinicopathological and biological variables in rectal cancer patients
Variables | Non-Radiotherapy | p-value | Radiotherapy | p-value | ||
|---|---|---|---|---|---|---|
| Â | Weak (%) | Strong (%) | Â | Weak (%) | Strong (%) | Â |
TNM stage | Â | Â | 0.92 | Â | Â | 0.07 |
   I | 9 (43) | 12 (57) |  | 11 (55) | 9 (45) |  |
   II | 6 (33) | 12 (67) |  | 6 (30) | 14 (70) |  |
   III | 10 (34) | 19 (66) |  | 2 (13) | 13 (87) |  |
   IV | 2 (40) | 3 (60) |  | 3 (43) | 4 (57) |  |
Cox-2 | Â | Â | 0.89 | Â | Â | 0.03 |
   Weak | 14 (37) | 24 (63) |  | 13 (50) | 13 (50) |  |
   Strong | 12 (35) | 22 (65) |  | 7 (22) | 25 (78) |  |
p73 | Â | Â | 0.11 | Â | Â | 0.01 |
   Weak | 13 (46) | 15 (54) |  | 11 (55) | 9 (45) |  |
   Strong | 12 (28) | 31 (72) |  | 9 (19) | 26 (81) |  |
PRL | Â | Â | 0.47 | Â | Â | 0.002 |
   Weak | 4 (44) | 5 (56) |  | 8 (73) | 3 (27) |  |
   Strong | 18 (32) | 38 (68) |  | 10 (24) | 32 (76) |  |